Cargando…
Glycemic and lipid variability for predicting complications and mortality in diabetes mellitus using machine learning
INTRODUCTION: Recent studies have reported that HbA1c and lipid variability is useful for risk stratification in diabetes mellitus. The present study evaluated the predictive value of the baseline, subsequent mean of at least three measurements and variability of HbA1c and lipids for adverse outcome...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8097996/ https://www.ncbi.nlm.nih.gov/pubmed/33947391 http://dx.doi.org/10.1186/s12902-021-00751-4 |
_version_ | 1783688423287029760 |
---|---|
author | Lee, Sharen Zhou, Jiandong Wong, Wing Tak Liu, Tong Wu, William K. K. Wong, Ian Chi Kei Zhang, Qingpeng Tse, Gary |
author_facet | Lee, Sharen Zhou, Jiandong Wong, Wing Tak Liu, Tong Wu, William K. K. Wong, Ian Chi Kei Zhang, Qingpeng Tse, Gary |
author_sort | Lee, Sharen |
collection | PubMed |
description | INTRODUCTION: Recent studies have reported that HbA1c and lipid variability is useful for risk stratification in diabetes mellitus. The present study evaluated the predictive value of the baseline, subsequent mean of at least three measurements and variability of HbA1c and lipids for adverse outcomes. METHODS: This retrospective cohort study consists of type 1 and type 2 diabetic patients who were prescribed insulin at outpatient clinics of Hong Kong public hospitals, from 1st January to 31st December 2009. Standard deviation (SD) and coefficient of variation were used to measure the variability of HbA1c, total cholesterol, low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C) and triglyceride. The primary outcome is all-cause mortality. Secondary outcomes were diabetes-related complications. RESULT: The study consists of 25,186 patients (mean age = 63.0, interquartile range [IQR] of age = 15.1 years, male = 50%). HbA1c and lipid value and variability were significant predictors of all-cause mortality. Higher HbA1c and lipid variability measures were associated with increased risks of neurological, ophthalmological and renal complications, as well as incident dementia, osteoporosis, peripheral vascular disease, ischemic heart disease, atrial fibrillation and heart failure (p < 0.05). Significant association was found between hypoglycemic frequency (p < 0.0001), HbA1c (p < 0.0001) and lipid variability against baseline neutrophil-lymphocyte ratio (NLR). CONCLUSION: Raised variability in HbA1c and lipid parameters are associated with an elevated risk in both diabetic complications and all-cause mortality. The association between hypoglycemic frequency, baseline NLR, and both HbA1c and lipid variability implicate a role for inflammation in mediating adverse outcomes in diabetes, but this should be explored further in future studies. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12902-021-00751-4. |
format | Online Article Text |
id | pubmed-8097996 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-80979962021-05-06 Glycemic and lipid variability for predicting complications and mortality in diabetes mellitus using machine learning Lee, Sharen Zhou, Jiandong Wong, Wing Tak Liu, Tong Wu, William K. K. Wong, Ian Chi Kei Zhang, Qingpeng Tse, Gary BMC Endocr Disord Research INTRODUCTION: Recent studies have reported that HbA1c and lipid variability is useful for risk stratification in diabetes mellitus. The present study evaluated the predictive value of the baseline, subsequent mean of at least three measurements and variability of HbA1c and lipids for adverse outcomes. METHODS: This retrospective cohort study consists of type 1 and type 2 diabetic patients who were prescribed insulin at outpatient clinics of Hong Kong public hospitals, from 1st January to 31st December 2009. Standard deviation (SD) and coefficient of variation were used to measure the variability of HbA1c, total cholesterol, low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C) and triglyceride. The primary outcome is all-cause mortality. Secondary outcomes were diabetes-related complications. RESULT: The study consists of 25,186 patients (mean age = 63.0, interquartile range [IQR] of age = 15.1 years, male = 50%). HbA1c and lipid value and variability were significant predictors of all-cause mortality. Higher HbA1c and lipid variability measures were associated with increased risks of neurological, ophthalmological and renal complications, as well as incident dementia, osteoporosis, peripheral vascular disease, ischemic heart disease, atrial fibrillation and heart failure (p < 0.05). Significant association was found between hypoglycemic frequency (p < 0.0001), HbA1c (p < 0.0001) and lipid variability against baseline neutrophil-lymphocyte ratio (NLR). CONCLUSION: Raised variability in HbA1c and lipid parameters are associated with an elevated risk in both diabetic complications and all-cause mortality. The association between hypoglycemic frequency, baseline NLR, and both HbA1c and lipid variability implicate a role for inflammation in mediating adverse outcomes in diabetes, but this should be explored further in future studies. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12902-021-00751-4. BioMed Central 2021-05-04 /pmc/articles/PMC8097996/ /pubmed/33947391 http://dx.doi.org/10.1186/s12902-021-00751-4 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Lee, Sharen Zhou, Jiandong Wong, Wing Tak Liu, Tong Wu, William K. K. Wong, Ian Chi Kei Zhang, Qingpeng Tse, Gary Glycemic and lipid variability for predicting complications and mortality in diabetes mellitus using machine learning |
title | Glycemic and lipid variability for predicting complications and mortality in diabetes mellitus using machine learning |
title_full | Glycemic and lipid variability for predicting complications and mortality in diabetes mellitus using machine learning |
title_fullStr | Glycemic and lipid variability for predicting complications and mortality in diabetes mellitus using machine learning |
title_full_unstemmed | Glycemic and lipid variability for predicting complications and mortality in diabetes mellitus using machine learning |
title_short | Glycemic and lipid variability for predicting complications and mortality in diabetes mellitus using machine learning |
title_sort | glycemic and lipid variability for predicting complications and mortality in diabetes mellitus using machine learning |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8097996/ https://www.ncbi.nlm.nih.gov/pubmed/33947391 http://dx.doi.org/10.1186/s12902-021-00751-4 |
work_keys_str_mv | AT leesharen glycemicandlipidvariabilityforpredictingcomplicationsandmortalityindiabetesmellitususingmachinelearning AT zhoujiandong glycemicandlipidvariabilityforpredictingcomplicationsandmortalityindiabetesmellitususingmachinelearning AT wongwingtak glycemicandlipidvariabilityforpredictingcomplicationsandmortalityindiabetesmellitususingmachinelearning AT liutong glycemicandlipidvariabilityforpredictingcomplicationsandmortalityindiabetesmellitususingmachinelearning AT wuwilliamkk glycemicandlipidvariabilityforpredictingcomplicationsandmortalityindiabetesmellitususingmachinelearning AT wongianchikei glycemicandlipidvariabilityforpredictingcomplicationsandmortalityindiabetesmellitususingmachinelearning AT zhangqingpeng glycemicandlipidvariabilityforpredictingcomplicationsandmortalityindiabetesmellitususingmachinelearning AT tsegary glycemicandlipidvariabilityforpredictingcomplicationsandmortalityindiabetesmellitususingmachinelearning |